We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gout Increases Risk of Advanced Chronic Kidney Disease

By LabMedica International staff writers
Posted on 11 Sep 2019
Chronic kidney disease (CKD) is a major public health epidemic, with at least 1 in 10 individuals having some degree of kidney impairment, contributing substantially to adverse clinical and economic outcomes.

Gout is the most common inflammatory arthritis, which causes severe pain and suffering due to a build-up of uric acid in joints. More...
It affects almost 2.5 % of the adult population and causes significant pain and disability due to its effects on joints, tendons and bone.

A team of scientists working with the University of Limerick (Limerick, Ireland) analyzed the risk of advanced chronic kidney disease (CKD) in 68,897 gout patients followed for an average of 3.7 years and compared them to 554,964 patients without gout. The primary and secondary outcome measures: Advanced CKD was defined as first occurrence of: (1) dialysis, kidney transplant, diagnosis of end-stage kidney disease (ESKD) or stage 5 CKD; (2) estimated glomerular filtration rate (eGFR) <10 mL/min/1.73 m²; (3) doubling of serum creatinine from baseline and (4) death associated with CKD.

The team reported that advanced CKD incidence was higher for patients with gout (8.54 per 1000 patient-years) versus without gout (4.08). Gout was associated with higher advanced CKD risk in both unadjusted analysis (Hazard ratio [HR], 2.00) and after adjustment (HR, 1.29). Association was strongest for ESKD (HR, 2.13) and was present for eGFR <10 mL/min/1.73 m² (HR, 1.45) and serum creatinine doubling (HR, 1.13), but not CKD-associated death (HR, 1.14) Association of gout with advanced CKD was replicated in propensity-score matched analysis (HR, 1.23) and analysis limited to patients with incident gout (HR, 1.28).

Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI, a Professor of Medicine and the lead author of the study, said, “We discovered that patients who suffered from gout had a 29% higher risk of advanced CKD compared to those without gout. Indeed when we analyzed each of the components of advanced kidney disease, we found that in general gout patients were at higher risk of deterioration in kidney function compared to those without. Astonishingly, when we looked at the risk of kidney failure and those who needed dialysis or a kidney transplant, we found that gouts patients had more than a 200% higher risk of kidney failure than those without gout.” The study was published on August 28, 2019, in the journal BMJ Open.

Related Links:
University of Limerick


Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.